Misuse and overuse of medical interventions that do not directly improve a patient’s health contribute significantly to the unsustainable growth of healthcare spending. ACP’s goal is to determine whether diagnostic tests and treatments for various diseases provide good value, i.e. medical benefits that are commensurate with their costs and outweigh any harm. We do this by analyzing their benefits, harms, and costs based on the best available evidence.
ACP's Clinical Guidelines and Recommendations provide clinicians information based on the best available evidence and help physicians and patients understand the benefits, harms, and costs of interventions and to determine whether services provide good value. Access ACP Guidelines and Clinical Recommendations
The High Value Care Recommendations provided in MKSAP® 16 are based on the medical knowledge content. They will inform physicians on diagnostic and management strategies for patients in specific clinical situations that balance clinical benefit with cost and harms with the goal of improving patient outcomes. Access MKSAP® Recommendations
ACP and Consumer Reports
Men between the ages of 50 and 69 should discuss the limited benefits and substantial harms of the prostate-specific antigen test with their doctor before undergoing screening for prostate cancer. Read the Full Article
In the News View All
- Breast MRI Use Up Despite Lack of Indications - Medpage Today
- Just Say No: 10 Common Medical Tests That May Do More Harm Than Good - Forbes
- ACP: Practicing high value care and overcoming patients' concerns - Kevin MD
High Value Care Videos
View our entire collection of videos
on High Value Care.